Literature DB >> 24327958

Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity.

Darren Opland1, Amy Sutton, Hillary Woodworth, Juliette Brown, Raluca Bugescu, Adriana Garcia, Lyndsay Christensen, Christopher Rhodes, Martin Myers, Gina Leinninger.   

Abstract

Neurons of the lateral hypothalamic area (LHA) control motivated behaviors such as feeding and ambulatory activity, in part by modulating mesolimbic dopamine (DA) circuits. The hormone, leptin, acts via the long form of the leptin receptor (LepRb) in the brain to signal the repletion of body energy stores, thereby decreasing feeding and promoting activity. LHA LepRb neurons, most of which contain neurotensin (Nts; LepRb(Nts) neurons) link leptin action to the control of mesolimbic DA function and energy balance. To understand potential roles for Nts in these processes, we examined mice null for Nts receptor 1 (NtsR1KO). While NtsR1KO mice consume less food than controls on a chow diet, they eat more and become obese when fed a high-fat, high-sucrose palatable diet; NtsR1KO mice also exhibit augmented sucrose preference, consistent with increased hedonic feeding in these animals. We thus sought to understand potential roles for NtsR1 in the control of the mesolimbic DA system and LHA leptin action. LHA Nts cells project to DA-containing midbrain areas, including the ventral tegmental area (VTA) and the substantia nigra (SN), where many DA neurons express NtsR1. Furthermore, in contrast to wild-type mice, intra-LHA leptin treatment increased feeding and decreased VTA Th expression in NtsR1KO mice, consistent with a role for NtsR1 signaling from LHA LepRb neurons in the suppression of food intake and control of mesolimbic DA function. Additionally, these data suggest that other leptin-regulated LHA neurotransmitters normally oppose aspects of Nts action to promote balanced responses to leptin.

Entities:  

Keywords:  DA, dopamine; Dopamine; LHA, lateral hypothalamic area; LepRb, long form of the leptin receptor; MCH, melanin concentrating hormone; NAc, nucleus accumbens; Neurotensin; Nts, neurotensin; NtsR1, neurotensin receptor-1; NtsR1KO, neurotensin receptor-1 knock out; NtsR2, neurotensin receptor-2; OX, Orexin/hypocretin; Obesity; Orexin; PD, palatable diet; SN, substantia nigra; TH, tyrosine hydroxylase; VTA, ventral tegmental area; pSTAT3, phosphorylation of signal transducer and activator of transcription 3

Year:  2013        PMID: 24327958      PMCID: PMC3857883          DOI: 10.1016/j.molmet.2013.07.008

Source DB:  PubMed          Journal:  Mol Metab        ISSN: 2212-8778            Impact factor:   7.422


  73 in total

1.  An autoradiographic study of the efferent connections of the lateral hypothalamic area in the rat.

Authors:  C B Saper; L W Swanson; W M Cowan
Journal:  J Comp Neurol       Date:  1979-02-15       Impact factor: 3.215

2.  Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study.

Authors:  F Sotty; F Soulière; P Brun; G Chouvet; R Steinberg; P Soubrié; B Renaud; M F Suaud-Chagny
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

3.  Synergistic effects of dopamine agonists and centrally administered neurotensin on feeding.

Authors:  M F Hawkins; C A Barkemeyer; R T Tulley
Journal:  Pharmacol Biochem Behav       Date:  1986-05       Impact factor: 3.533

4.  SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.

Authors:  R Steinberg; P Brun; M Fournier; J Souilhac; D Rodier; G Mons; J P Terranova; G Le Fur; P Soubrié
Journal:  Neuroscience       Date:  1994-04       Impact factor: 3.590

5.  The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.

Authors:  Kristin E Smith; Mona Boules; Katrina Williams; Abdul H Fauq; Elliott Richelson
Journal:  Behav Brain Res       Date:  2011-06-21       Impact factor: 3.332

6.  Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.

Authors:  M Cador; A E Kelley; M Le Moal; L Stinus
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation.

Authors:  Carolina Birgner; Karin Nordenankar; Martin Lundblad; José Alfredo Mendez; Casey Smith; Madeleine le Grevès; Dagmar Galter; Lars Olson; Anders Fredriksson; Louis-Eric Trudeau; Klas Kullander; Asa Wallén-Mackenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

8.  Direct innervation of GnRH neurons by metabolic- and sexual odorant-sensing leptin receptor neurons in the hypothalamic ventral premammillary nucleus.

Authors:  Rebecca L Leshan; Gwendolyn W Louis; Young-Hwan Jo; Christopher J Rhodes; Heike Münzberg; Martin G Myers
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

9.  Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA.

Authors:  Kimberly A Kempadoo; Clara Tourino; Saemi L Cho; Francesco Magnani; Gina-Marie Leinninger; Garret D Stuber; Feng Zhang; Martin G Myers; Karl Deisseroth; Luis de Lecea; Antonello Bonci
Journal:  J Neurosci       Date:  2013-05-01       Impact factor: 6.167

10.  Hypothalamic orexin neurons regulate arousal according to energy balance in mice.

Authors:  Akihiro Yamanaka; Carsten T Beuckmann; Jon T Willie; Junko Hara; Natsuko Tsujino; Michihiro Mieda; Makoto Tominaga; Ken ichi Yagami; Fumihiro Sugiyama; Katsutoshi Goto; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Neuron       Date:  2003-06-05       Impact factor: 17.173

View more
  48 in total

1.  Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABAA and GABAB receptor-mediated synaptic input.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Neuropharmacology       Date:  2018-01-05       Impact factor: 5.250

Review 2.  Cognitive and autonomic determinants of energy homeostasis in obesity.

Authors:  Denis Richard
Journal:  Nat Rev Endocrinol       Date:  2015-06-30       Impact factor: 43.330

Review 3.  The gut sensor as regulator of body weight.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  Endocrine       Date:  2014-12-30       Impact factor: 3.633

4.  Eating "junk food" has opposite effects on intrinsic excitability of nucleus accumbens core neurons in obesity-susceptible versus -resistant rats.

Authors:  Max F Oginsky; Carrie R Ferrario
Journal:  J Neurophysiol       Date:  2019-07-31       Impact factor: 2.714

Review 5.  Homeostasis Meets Motivation in the Battle to Control Food Intake.

Authors:  Carrie R Ferrario; Gwenaël Labouèbe; Shuai Liu; Edward H Nieh; Vanessa H Routh; Shengjin Xu; Eoin C O'Connor
Journal:  J Neurosci       Date:  2016-11-09       Impact factor: 6.167

Review 6.  Lateral hypothalamic area neuropeptides modulate ventral tegmental area dopamine neurons and feeding.

Authors:  Patricia Perez-Bonilla; Krystal Santiago-Colon; Gina M Leinninger
Journal:  Physiol Behav       Date:  2020-05-31

Review 7.  Hormonal and neural mechanisms of food reward, eating behaviour and obesity.

Authors:  Susan Murray; Alastair Tulloch; Mark S Gold; Nicole M Avena
Journal:  Nat Rev Endocrinol       Date:  2014-06-24       Impact factor: 43.330

8.  Arcuate neuropeptide Y inhibits sympathetic nerve activity via multiple neuropathways.

Authors:  Zhigang Shi; Christopher J Madden; Virginia L Brooks
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 9.  The role of leptin in health and disease.

Authors:  Angela M Ramos-Lobo; Jose Donato
Journal:  Temperature (Austin)       Date:  2017-05-26

10.  Computational Analysis of the Hypothalamic Control of Food Intake.

Authors:  Shayan Tabe-Bordbar; Thomas J Anastasio
Journal:  Front Comput Neurosci       Date:  2016-04-26       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.